Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$381.09 - $495.99 $269,049 - $350,168
-706 Reduced 49.75%
713 $322,000
Q1 2024

May 15, 2024

SELL
$308.3 - $463.55 $282,711 - $425,075
-917 Reduced 39.26%
1,419 $658,000
Q4 2023

Feb 15, 2024

BUY
$289.29 - $409.7 $527,664 - $747,292
1,824 Added 356.25%
2,336 $885,000
Q3 2023

Nov 07, 2023

SELL
$401.2 - $581.79 $5,616 - $8,145
-14 Reduced 2.66%
512 $212,000
Q2 2023

Aug 03, 2023

SELL
$500.0 - $659.0 $80,000 - $105,440
-160 Reduced 23.32%
526 $298,000
Q1 2023

May 04, 2023

BUY
$565.0 - $694.87 $181,365 - $223,053
321 Added 87.95%
686 $431,000
Q4 2022

Feb 13, 2023

BUY
$551.1 - $688.5 $169,187 - $211,369
307 Added 529.31%
365 $204,000
Q3 2022

Nov 03, 2022

SELL
$545.43 - $680.3 $6,545 - $8,163
-12 Reduced 17.14%
58 $33,000
Q2 2022

Aug 12, 2022

SELL
$605.0 - $763.25 $99,220 - $125,173
-164 Reduced 70.09%
70 $44,000
Q1 2022

May 16, 2022

SELL
$601.4 - $763.0 $876,841 - $1.11 Million
-1,458 Reduced 86.17%
234 $167,000
Q4 2021

Feb 14, 2022

BUY
$650.15 - $802.0 $695,660 - $858,140
1,070 Added 172.03%
1,692 $1.19 Million
Q3 2021

Nov 09, 2021

BUY
$594.24 - $758.0 $209,172 - $266,816
352 Added 130.37%
622 $434,000
Q2 2021

Aug 13, 2021

SELL
$582.88 - $670.99 $529,837 - $609,929
-909 Reduced 77.1%
270 $167,000
Q1 2021

May 13, 2021

BUY
$619.2 - $736.0 $351,086 - $417,312
567 Added 92.65%
1,179 $756,000
Q4 2020

Feb 11, 2021

SELL
$576.6 - $672.2 $20,181 - $23,527
-35 Reduced 5.41%
612 $394,000
Q3 2020

Nov 12, 2020

SELL
$620.1 - $689.89 $79,372 - $88,305
-128 Reduced 16.52%
647 $405,000
Q2 2020

Aug 12, 2020

BUY
$610.05 - $713.9 $181,794 - $212,742
298 Added 62.47%
775 $493,000
Q1 2020

May 13, 2020

SELL
$615.5 - $751.4 $587,187 - $716,835
-954 Reduced 66.67%
477 $310,000
Q4 2019

Feb 10, 2020

BUY
$688.5 - $846.15 $499,162 - $613,458
725 Added 102.69%
1,431 $1.08 Million
Q3 2019

Nov 14, 2019

SELL
$722.04 - $840.0 $210,835 - $245,280
-292 Reduced 29.26%
706 $550,000
Q2 2019

Aug 14, 2019

BUY
$837.83 - $927.0 $444,887 - $492,237
531 Added 113.7%
998 $851,000
Q1 2019

May 15, 2019

BUY
$709.9 - $885.4 $217,939 - $271,817
307 Added 191.88%
467 $410,000
Q4 2018

Feb 14, 2019

SELL
$667.94 - $785.7 $346,660 - $407,778
-519 Reduced 76.44%
160 $119,000
Q3 2018

Nov 14, 2018

BUY
$602.8 - $699.6 $286,932 - $333,009
476 Added 234.48%
679 $472,000
Q2 2018

Aug 14, 2018

SELL
$568.25 - $635.8 $93,761 - $104,906
-165 Reduced 44.84%
203 $121,000
Q1 2018

May 15, 2018

SELL
$526.8 - $633.85 $95,877 - $115,360
-182 Reduced 33.09%
368 $232,000
Q4 2017

Feb 14, 2018

BUY
$620.6 - $689.35 $134,670 - $149,588
217 Added 65.17%
550 $346,000
Q3 2017

Nov 14, 2017

BUY
$608.7 - $680.0 $202,697 - $226,440
333
333 $224,000

Others Institutions Holding ATRI

About ATRION CORP


  • Ticker ATRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 1,785,990
  • Description
  • Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...
More about ATRI
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.